Sign in
4

Changes in Ownership

Contineum Therapeutics, Inc. Filed Acc 0001628280-26-039641

Chief Scientific Officer sold 4,170 shares at $13.16 ($54,862)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lorrain Daniel S. Chief Scientific Officer 2026-06-01 Sale 10b5-1 −4,170 $13.16 $54,862 139,372 D
Open-market sales · 4,170 sh · avg $13.16 · $54,862
Loading xslF345X06/wk-form4_1780351717.xml…